Most cardiac devices do not fit young children, making it especially important for growth in pediatric cardiology to continue. The FDA helped fund a contest aimed at identifying new devices that show a ton of potential. 

Dynocardia has now received nearly $5.1 million in funding from the NHLBI to help speed commercializing its wrist-worn monitor to avoid the need for invasive catheter BP monitoring.

The new report could go on to help guide decisions made by CMS and hospital leadership teams for years to come.

Today's heart teams already face a number of challenges on a day-to-day basis.  New data suggest they could soon be treating more patients than ever before.  

The new Cordella device from Endotronix, now an Edwards Lifesciences company, uses an implantable device to track the patient's pulmonary artery pressure and other helpful health data.

Cardiologists and other physicians may soon need to provide much more information when ordering remote patient monitoring for Medicare patients.

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

HeartKey Rhythm was designed to help care teams keep up with the rising amount of ECG data they receive on a regular basis.